FDA Panel Calls For More Studies Of Mini-Slings For Urinary Incontinence

FDA’s Obstetrics and Gynecology Device panel recommends second-generation mini-slings to treat stress urinary incontinence be subject to 510(k) pre-market clinical trial requirements and additional post-market data collection mandates.